In August 2022, the first participant was enrolled and received the study drug in our Phase 1 food effect study. This study is examining the effect of food on the bioavailability of MDMA in healthy volunteers …
In July 2022, the MDMA Therapy Training team delivered training for Naropa University’s inaugural psychedelic-assisted therapies certificate cohort. The training retreat was hosted at Drala Mountain …
As of August 8, 2022, a total of five participants have been enrolled and the Bronx VA site continues to actively screen for new participants. Enrollment is continuing for this Phase 2, open-label study …
On July 28, 2022, the first participant was screened for the Phase 1 food effects study. This study is enrolling healthy volunteers and examines the effect of food on the bioavailability of MDMA. The …
In June 2022, the MDMA Therapy Training Team delivered two more trainings, including a week-long in-person training retreat in New York and a week-long training in California in collaboration with the …
“I have worked with a lot of medicine on my healing journey. Dozens of ayahuasca ceremonies. Extensive experience with psilocybin, ketamine, kambo, and deep sessions with 5-MeO. While I’ve had …
Enrollment is continuing for our Phase 2, open-label study on the effectiveness of MDMA-assisted therapy in U.S. Veterans with chronic PTSD. This study is a comparative study that assesses two versus three …
Jason Luoma, Ph.D., of Portland Psychotherapy, is the sponsor and Principal Investigator for SAMATI, an exploratory study to investigate the safety and preliminary efficacy of MDMA-assisted therapy for …
Training staff and contractors pictured above, from left to right: Sara Gael Giron, Corey Westbury, Veena Muthusamy, Nicole Sylvestre, Chris Stauffer, Ryan Beauregard, Wesley Hale, Christine Penny, Bruce …
Summary: The New York Times publishes an investigative article exploring the impact of PTSD and moral injury in Veterans, highlighting published data from MAPS-sponsored clinical trials of MDMA-assisted …
Two new study sites are now enrolling for our MDMA-assisted therapy for PTSD Expanded Access program. The Pearl Institute in Waynesville, North Carolina, and Sage Integrative Health in Berkeley, California, …
The MAPS Europe team is delighted to announce that screening of participants for our open-label Phase 2 study of MDMA-assisted therapy for PTSD has begun at the Charité – Universitätsmedizin Berlin …
